+1 915 229 3004 (U.S.) | 
+44 7452 242832 (U.K.)
+1 915 229 3004 (U.S.) | +44 7452 242832 (U.K.)
The global Legionella Testing Market is projected to reach USD 376.66 million by 2030, from USD 231.83 million in 2020, and is anticipated to register a CAGR of 8.7% between 2021 and 2030.
Download Free Report Sample to learn more about this report.
Every area of the delivery of healthcare and medical services in the U.S. was affected by the COVID-19 epidemic. Following the initial COVID-19 crisis wave, a further rise in legionellosis was seen as a result of postponed or canceled hospital or clinic appointments. Furthermore, individuals with a variety of health issues found it difficult to get prompt care, primarily because of misunderstandings and anxieties about quarantine orders. In 2020, COVID-19 had an immediate and unexpectedly high demand for legionella testing, necessitating safe, prompt, and ongoing access to diagnosis while avoiding in-person interaction. As COVID-19 grew over the globe, encouraged by loose government laws, numerous hospitals, clinics, and private diagnostic facilities soon adapted to rapid legionella testing.
Drivers:
Escalating Prevalence of Legionellosis
Despite all the safeguards and personal hygiene measures adopted, the number of patients with legionellosis is increasing globally. While safety measures for the cleanliness of potable water are deteriorating, which can be held as one of the most prominent factors for the rising incidence rate of legionellosis worldwide, especially across developing and emerging countries, including Southeast Asian countries, Middle Eastern, African, and Western European countries, precaution and hygiene are the essential factors in the prevention of legionellosis. The severity of legionellosis is significantly higher in older adults over the age of 50. About 60–70% of reported cases are male, while 75–80% of recorded cases are above 50. Smoking and brief travel history are two additional risk factors for community-acquired and travel-associated legionellosis. Smoking, a recent history of heavy and continuous drinking, lung illnesses and diseases, immunological suppression, and chronic respiratory or renal diseases and disorders are additional risk factors for both community-acquired and travel-associated legionellosis.
The global legionella testing market is anticipated to grow as a result of improvements in point-of-care diagnostics brought on by the rising prevalence of infectious disorders. In addition, the global market for legionella testing is experiencing substantial expansion due to accurate, early, and speedy diagnosis of legionellosis.
Rise in Patient Awareness towards Legionellosis Diagnosis
Numerous lives were lost in the early days as a result of late and inaccurate diagnoses of legionellosis brought on by insufficient tools, subpar diagnostic techniques, and a general lack of knowledge about disease diagnosis. The market for legionella testing began to take off globally due to improvements in legionella testing processes, tools, and reagents. Additionally, since 2014, legionellosis's frequency and incidence rate have increased globally. In many regions, the number of cases in 2020 compared to 2019 has increased by roughly 23%. Increased awareness has resulted from the rapid escalation of disease problems among people in industrialized, emerging, developing, and underdeveloped nations.
Patient knowledge is of the utmost significance during legionella testing since it leads to an accurate and prompt diagnosis. Correct therapy for legionellosis is further aided by precise diagnosis. The patient is now becoming more aware of early diagnosis, also known as preventive diagnostics. The global market for legionella testing is anticipated to be further boosted by the general increase in the patient pool with high illness diagnosis awareness.
Legionella Testing Market Restraints:
Dearth of Skilled Professionals
The rapidly increasing number of patients and a larger number of available tests means more samples are being tested in the laboratory. On the other hand, there is a shortage of laboratory staff to process the samples and to keep up with the growing demand. Some developed and developing countries need help finding qualified people to work in legionella testing. According to CNN Business, there will be a shortage of 98,700 medical technologists and technicians in the United States by 2025. Additionally, a decline in interest and limited engagement in legionella testing procedures among many healthcare professionals can be attributed to researchers' insufficient understanding of the benefits connected with legionella testing.
Another expert assessment revealed that the crisis has been building for more than ten years due to insufficient skill training provided by CROs or Pharma for graduates to satisfy the needs of the diagnostic testing business. All of this could impede market growth to some extent, but it is not a problem that cannot be managed. On the contrary, the total Legionella Testing Market development may benefit by streamlining diagnostic and testing procedures, training more individuals or healthcare professionals, and providing accurate and exact testing services for legionellosis.
Legionella Testing Market Opportunities:
Lucrative Opportunities Offered by Commercialization Services
The most substantial return on investments in diagnostic and legionella testing is what drives the market's dynamics. To attain larger economies of scale, effective commercialization services are required, which include creating a flexible and affordable commercialization strategy for goods still through clinical trials. Startup businesses without the necessary commercial infrastructure to commercialize their goods on the market but with promising products in Phase III clinical trials can benefit significantly from commercialization services. For example, blockbuster testing gadgets from biopharmaceutical companies will need a dynamic launch team that can quickly adapt to market realities. The legionella testing market participants providing commercialization services gather evidence in real-time to get product authorization, hasten market entry, and promote product uptake. The legionella testing industry is thriving and supported by technological improvements in legionella testing instruments, providing startup businesses operating in this legionella testing market with significant growth potential.
Download Free Report Sample to learn more about this report.
Based on product type, the global legionella testing market is segmented into human and environment. Environment tests for detection of legionella bacteria are continuously performed by various water bodies across the globe. Diagnostic tests in human for legionella is performed when outbreak is encountered.
Environment sub segment dominated the segment by holding 75.89% of share for legionella testing market. Reducing the likelihood of Legionella growth and spread in the environment is the best strategy to prevent and control legionellosis. It is advised that building owners, proprietors of commercial properties, hotel owners and managers, operators of public hot tubs, and anyone who works near or for water bodies manage and maintain their water systems and put legionella controls in place. Swimming pools, air conditioning systems, water cooling systems, fountains, hot water systems, and spas are routinely monitored by sample collection and laboratory analysis to stop legionella from spreading in water bodies and the general environment.
Download Free Report Sample to learn more about this report.
Europe has covered the largest share in the legionella testing market during the prediction.
Europe is thought to be largest market during the analysis and prediction. High pharmaceutical sector R&D spending and the rising incidence of legionellosis are factors driving the expansion of this legionella testing market.
Germany is predicted to dominate the regional legionella testing market every year in the European region due to the increased clinical trials for legionella diagnostic equipment and the rising number of clinical studies overall. Additionally, the regional market observed a shift in emphasis toward higher legionella testing and increased testing outsourcing by the companies. In addition, the use of the Q&D approach in pharmaceutical and research manufacturing, along with the help of FTE contacts in R&D outsourcing, are essential drivers of the development and expansion of the Europe legionella testing market when taking into account the overall situation.
Some of the major key player operating in the legionella testing market are Eurofins Scientific, Biomerieux, Bio-Rad Laboratories Inc, IDEXX, Alere Inc, Thermo Fischer Scientific Inc, Becton Dickinson and Company, Albagaia, Pacific Water Technology, and Phigenics.
· In July 2019, Two Legionella prevention companies LiquiTech and Spartan Bioscience have partnered to eliminate Legionnaires’ outbreaks in the healthcare sector. They will use innovative environmental DNA testing platform to provide a new approach to detecting Legionella contamination and control unparalleled control of Legionnaires’ disease in health care and hospitality environments.
· In October 2020, acquisition of Eaton Environmental Services Limited was announced by Rochester Midland Corporation.
· In February 2019, Asahi Kasei Pharma launched the sale of Ribotes Legionella in Japan as a new product in the Ribotest series of extracorporeal diagnostic kits. This assists the diagnosis of Legionnaires’ disease by detecting all 15 serogroups of Legionella pneumophila.
· Oxford Biosystems introduced Legionella Water test breakthrough in June 2018, at WMSoc Conference. It provides precise outcomes within 4 hours.
This report categorizes the Legionella Testing market as follows:
The global Legionella Testing market is projected to reach USD 376.66 million by 2030, from USD 231.83 million in 2020 and is anticipated to register a CAGR of 8.7% between 2021 and 2030.
Europe is thought to be largest market during the analysis and prediction in 2030.
Environment sub segment dominated the segment by holding 75.89% of share for legionella testing market
Eurofins Scientific, Biomerieux, Bio-Rad Laboratories Inc, IDEXX, Alere Inc, Thermo Fischer Scientific Inc, Becton Dickinson and Company, Albagaia, Pacific Water Technology, Phigenics.
Report Code :
RL6517
Published on :
Nov 2022
Request a Free Sample Report
Speak to Analyst